Theragnostic imaging for radiation oncology: dose-painting by numbers

被引:325
作者
Bentzen, SM [1 ]
机构
[1] Univ Wisconsin, Sch Med, Dept Human Oncol, Ctr Clin Sci, Madison, WI 53792 USA
关键词
D O I
10.1016/S1470-2045(05)01737-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Theragnostic imaging for radiation oncology is the use of molecular and functional imaging to prescribe the distribution of radiation in four dimensions-the three dimensions of space plus time-of radiotherapy alone or combined with other treatment modalities in an individual patient. Several new imaging targets for positron-emission tomography, single-photon-emission CT, and magnetic resonance spectroscopy allow variations in microenvironmental or cellular phenotypes that modulate the effect of radiation to be mapped in three dimensions. Dose-painting by numbers is a strategy by which the dose distribution delivered by inverse planned intensity-modulated radiotherapy is prescribed in four dimensions. This approach will revolutionise the way that radiotherapy is prescribed and planned and, at least in theory, will improve the therapeutic outcome in terms of local tumour control and side-effects to unaffected tissue.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 39 条
[1]   On biologically conformal boost dose optimization [J].
Alber, M ;
Paulsen, F ;
Eschmann, SM ;
Machulla, HJ .
PHYSICS IN MEDICINE AND BIOLOGY, 2003, 48 (02) :N31-N35
[2]  
Ang KK, 2002, CANCER RES, V62, P7350
[3]   High-tech in radiation oncology: Should there be a ceiling? [J].
Bentzen, SM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (02) :320-330
[4]   Repopulation in radiation oncology: perspectives of clinical research [J].
Bentzen, SM .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2003, 79 (07) :581-585
[5]  
BENTZEN SM, 2002, BASIC CLIN RADIOBIOL, P134
[6]   Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology [J].
Bernier, J ;
Bentzen, SM .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (05) :560-571
[7]   Clinical and physical quality assurance for intensity modulated radiotherapy of prostate cancer [J].
Boehmer, D ;
Bohsung, J ;
Eichwurzel, I ;
Moys, A ;
Budach, V .
RADIOTHERAPY AND ONCOLOGY, 2004, 71 (03) :319-325
[8]   Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography [J].
Bos, R ;
van der Hoeven, JJM ;
van der Wall, E ;
van der Groep, P ;
van Diest, PJ ;
Comans, EFI ;
Joshi, U ;
Semenza, GL ;
Hoekstra, OS ;
Lammertsma, AA ;
Molthoff, CFM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :379-387
[9]   Intensity-modulated radiotherapy: Current status and issues of interest [J].
Boyer, AL ;
Butler, EB ;
DiPetrillo, TA ;
Engler, MJ ;
Fraass, B ;
Grant, W ;
Ling, CC ;
Low, DA ;
Mackie, TR ;
Mohan, R ;
Purdy, JA ;
Roach, M ;
Rosenman, JG ;
Verhey, LJ ;
Wong, JW ;
Cumberlin, RL ;
Stone, H ;
Palta, JR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :880-914
[10]  
Buck AK, 2002, CANCER RES, V62, P3331